NETRIS Pharma is a clinical-stage biopharmaceutical company developing innovative therapeutic solutions targeting Netrin-1, a novel mechanism in oncology and inflammatory diseases
NETRIS Pharma is a clinical-stage biopharmaceutical company developing innovative therapeutic solutions targeting Netrin-1, a novel mechanism in oncology and inflammatory diseases. Their lead product, NP137, is an anti-Netrin-1 monoclonal antibody in clinical development for various cancers and endometriosis.